CRIS Current Research Information System

MARTELLI, ALBERTO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.739
EU - Europa 10.046
AS - Asia 8.907
SA - Sud America 729
AF - Africa 674
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 35.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.635
SG - Singapore 2.868
GB - Regno Unito 2.633
CN - Cina 2.537
IT - Italia 1.635
VN - Vietnam 1.564
DE - Germania 1.539
SE - Svezia 1.229
HK - Hong Kong 828
RU - Federazione Russa 571
UA - Ucraina 571
IN - India 539
BR - Brasile 503
FR - Francia 422
IE - Irlanda 377
ZA - Sudafrica 239
EE - Estonia 219
NL - Olanda 194
TG - Togo 165
FI - Finlandia 134
JP - Giappone 129
KR - Corea 111
CH - Svizzera 102
CI - Costa d'Avorio 96
SC - Seychelles 94
AR - Argentina 91
JO - Giordania 82
BG - Bulgaria 71
AT - Austria 66
BE - Belgio 65
ID - Indonesia 65
CA - Canada 60
HR - Croazia 57
EC - Ecuador 48
NG - Nigeria 45
MX - Messico 28
GR - Grecia 27
PL - Polonia 26
CL - Cile 25
BD - Bangladesh 24
IR - Iran 24
CO - Colombia 21
ES - Italia 21
TR - Turchia 21
PK - Pakistan 20
AU - Australia 17
CZ - Repubblica Ceca 14
UZ - Uzbekistan 14
RO - Romania 13
LT - Lituania 12
PE - Perù 11
PY - Paraguay 11
LB - Libano 10
MY - Malesia 10
PT - Portogallo 10
HU - Ungheria 9
IQ - Iraq 9
VE - Venezuela 9
NZ - Nuova Zelanda 7
PH - Filippine 7
UY - Uruguay 7
EG - Egitto 6
MA - Marocco 6
TH - Thailandia 6
NP - Nepal 5
SA - Arabia Saudita 5
AM - Armenia 4
DK - Danimarca 4
KE - Kenya 4
MD - Moldavia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
ZW - Zimbabwe 2
Totale 35.107
Salva come PNG Salva come JPEG
Città #
Southend 2.311
Fairfield 1.818
Singapore 1.775
Ashburn 1.449
Chandler 1.002
Woodbridge 913
Houston 855
Santa Clara 822
Hong Kong 817
Wilmington 775
Seattle 766
Cambridge 616
Ann Arbor 614
Princeton 577
Dong Ket 525
Bologna 459
Dublin 375
Boardman 370
Beijing 366
Jacksonville 334
Hefei 290
Nanjing 274
Westminster 253
Ho Chi Minh City 242
Padova 219
Hanoi 211
Los Angeles 180
Berlin 172
Lomé 165
Dallas 157
San Diego 132
Saint Petersburg 125
Jinan 118
Tokyo 116
Helsinki 105
Buffalo 104
Shenyang 102
New York 100
Seoul 100
Abidjan 96
Milan 92
Redondo Beach 87
Turin 87
Frankfurt am Main 82
Amman 81
Bremen 81
Changsha 81
Bern 78
Redmond 78
Mülheim 73
Nanchang 71
Sofia 70
Hebei 67
Brussels 58
Tianjin 55
Guangzhou 53
São Paulo 49
Shanghai 48
Florence 46
Munich 45
Abeokuta 44
Nuremberg 44
Des Moines 43
Jiaxing 42
Dearborn 41
Falkenstein 39
Norwalk 39
Rome 39
Yubileyny 39
Zhengzhou 38
Medford 37
Washington 37
Chicago 36
London 36
Mahé 35
Vienna 34
Haikou 33
Jakarta 33
Falls Church 32
Redwood City 32
Amsterdam 30
Hangzhou 27
Da Nang 26
Bühl 25
Phoenix 25
Haiphong 24
Ningbo 24
San Francisco 24
Verona 24
Olalla 23
Toronto 23
Council Bluffs 22
Kunming 22
Taiyuan 22
Taizhou 21
Udine 21
Brooklyn 20
Fuzhou 19
Mountain View 19
Paris 19
Totale 23.395
Salva come PNG Salva come JPEG
Nome #
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? 262
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 244
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 236
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 236
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 223
INPP4B overexpression and c-KIT downregulation in human achalasia. 219
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 208
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 208
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. 203
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 201
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma 201
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 200
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene 197
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 191
COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML) 187
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 186
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases 186
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. 184
Therapeutic targeting of CK2 in acute and chronic leukemias. 184
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 182
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 181
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 181
Cancer therapy and treatments during COVID-19 era 181
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 180
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 179
Revisiting nuclear phospholipase C signalling in MDS 177
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 177
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 177
Nuclear inositides: facts and perspectives. 175
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 174
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 173
Inositide signaling in the nucleus: From physiology to pathology. 173
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 171
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 170
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 169
Regulation of nuclear phospholipase C activity 167
Cutting edge: the role of mTOR signaling in laminopathies. 166
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 165
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 165
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress 164
Quantitative immunodetection of key elements of polyphosphoinositide signal transduction in osteoblasts from arthritic patients shows a direct correlation with cell proliferation 163
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 162
Nuclear protein kinase C isoforms and apoptosis 161
Advances in Targeting Signal Transduction Pathways. 161
Nuclear phospholipase C beta1 and cellular differentiation. 160
Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells 160
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 160
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 160
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 159
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 159
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 158
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 157
Nuclear inositol lipid metabolism: more than just second messenger generation? 157
Nuclear protein kinase C 156
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 156
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 155
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 155
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 155
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction 154
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 153
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 153
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 152
COMBINAZIONE DI EPZ-5676 E SORAFENIB COME NUOVA STRATEGIA TERAPEUTICA PER IL TRATTAMENTO DELLE LEUCEMIE ACUTE MIELOIDI PEDIATRICHE 151
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 151
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma 151
Signal transduction within the nucleus: Revisiting phosphoinositide inositide-specific phospholipase Cbeta(1). 150
Physiology and pathology of nuclear phospholipase C beta1 150
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 150
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway 149
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 147
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 146
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 146
Significance of subnuclear licalization of key players of inositol lipid cycle. 145
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 145
null 144
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 144
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 144
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 143
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 142
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 142
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 142
Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta. 142
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 142
Pathobiology and therapeutic relevance of GSK-3 in chronic hematological malignancies. 140
Nuclear inositide signaling in myelodysplastic syndromes. 139
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 139
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 139
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 138
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 138
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 138
PKR Activity Is Required for Acute Leukemic Cell Maintenance and Growth: A Role for PKR-Mediated Phosphatase Activity to Regulate GSK-3 Phosphorylation. 138
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 137
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 137
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 137
Targeting CTLA-4 by its recombinant ligands CD80/CD86: Perspectives towards the development of a novel anti-tumor therapeutic approach. 137
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression 136
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by alpha-actinin 136
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 136
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment 136
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation 136
Totale 16.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.047 0 0 0 0 0 159 67 217 287 182 165 970
2021/20225.039 553 135 348 378 446 292 156 352 152 605 808 814
2022/20234.733 547 615 258 680 335 345 211 258 783 88 402 211
2023/20241.371 83 212 123 103 149 290 74 65 43 100 52 77
2024/20255.325 120 849 507 334 1.216 328 372 184 76 229 150 960
2025/20265.973 819 1.217 1.195 848 1.475 419 0 0 0 0 0 0
Totale 35.852